3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
7
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
5
Urinary Bladder Neoplasms
4
Mesothelioma, Malignant
4
Urethral Neoplasms
3
Small Cell Lung Carcinoma
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Medulloblastoma
3
Ganglioneuroblastoma
3
Cholangiocarcinoma
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Ureteral Neoplasms
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Vomiting
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Solitary Fibrous Tumor, Pleural
1
Sertoli-Leydig Cell Tumor
1
Interventions
Sorafenib
23
Bevacizumab
11
Radiosurgery
6
Capecitabine
6
Radiofrequency Ablation
5
Oxaliplatin
5
Fluorouracil
5
Doxorubicin
5
pembrolizumab
4
Sunitinib
4
Erlotinib Hydrochloride
4
Cisplatin
4
Ramucirumab
3
Radiotherapy
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
tremelimumab
2
spartalizumab
2
perflutren
2
derazantinib
2
carotuximab
2
Mitomycin
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Ipilimumab
2
Immunohistochemistry
2
Gemcitabine
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liver Neoplasms
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
No trials found.